Related Experiment Video
Updated: Jul 19, 2026

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Published on: May 17, 2014
When translation meets transformation: the mTOR story
Abstract:
There is currently a high level of interest in signalling through the mammalian target of rapamycin (mTOR). This reflects both its key role in many cell functions and its involvement in disease states such as cancers. The best understood targets for mTOR signalling are proteins involved in controlling the translational machinery, including the ribosomal protein S6 kinases and proteins that regulate the initiation and elongation phases of translation. Indeed, there is compelling evidence that at least one of these targets of mTOR (eukaryotic initiation factor eIF4E) plays a key role in tumorigenesis. It is regulated through the mTOR-dependent phosphorylation of inhibitory proteins such as eIF4E-binding protein 1. Thus, targeting mTOR signalling may be an effective anticancer strategy, in at least a significant subset of tumours. Not all effects of mTOR are sensitive to the classical anti-mTOR drug rapamycin, and this compound also interferes with other processes besides eIF4E function. Developing new approaches to targeting mTOR for cancer therapy requires more detailed knowledge of signalling downstream of mTOR. Such advances are likely to come from further work to understand the regulation of mTOR targets such as components of the translational apparatus.
Insights
The mammalian target of rapamycin (mTOR) pathway is crucial for cell function and cancer. Understanding mTOR targets, like eukaryotic initiation factor eIF4E, is key for developing new cancer therapies.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- The mammalian target of rapamycin (mTOR) pathway is a central regulator of cell growth, metabolism, and proliferation.
- Dysregulation of mTOR signaling is implicated in various diseases, particularly cancers.
- Key mTOR targets include proteins controlling protein synthesis, such as eukaryotic initiation factor eIF4E.
Purpose of the Study:
- To investigate the role of mTOR signaling in tumorigenesis.
- To explore the regulation of mTOR targets, specifically eukaryotic initiation factor eIF4E, in cancer.
- To identify new therapeutic strategies targeting the mTOR pathway for cancer treatment.
Main Methods:
- Analysis of mTOR-dependent phosphorylation of regulatory proteins.
- Investigation of the role of eukaryotic initiation factor eIF4E in tumor development.
- Examination of signaling pathways downstream of mTOR.
Main Results:
- mTOR signaling significantly influences the translational machinery.
- eukaryotic initiation factor eIF4E, a direct target of mTOR, plays a critical role in cancer.
- Regulation of eIF4E involves mTOR-dependent phosphorylation of inhibitory proteins like eIF4E-binding protein 1.
Conclusions:
- Targeting mTOR signaling presents a promising anticancer strategy for a subset of tumors.
- Further research into mTOR downstream signaling is essential for developing novel cancer therapies.
- Understanding the regulation of translational components by mTOR is crucial for advancing cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
PI3K/mTOR/AKT Signaling Pathway
Termination of Translation

